A series of 2-(4-arylbutadienyl)benzoxazole derivatives and an oxazolopyridine derivative were prepared and their 5-lipoxygenase inhibitory activities were evaluated. A number of compounds showed 50% inhibition in the range of 10(-8) similar to 10(-7) M.